2024 Ntla stock forecast - The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$30.65

 
The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +137.08% increase from the last price of 30.37. The current consensus among 27 polled investment analysts is to Buy stock in Intellia .... Ntla stock forecast

Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance١٨‏/٠٤‏/٢٠٢٣ ... Analysts are bullish on NTLA stock. It currently has a mean price ... price and institutional investors own approximately 85% of the stock.(See NTLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks’ equity insights.The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +137.08% increase from the last price of 30.37. The current consensus among 27 polled investment analysts is to Buy stock in Intellia ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceBionano Genomics Inc () Stock Market info Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.According to present data Bionano Genomics's BNGO shares and potentially its …Even after rising 30% so far this year, shares of Intellia Therapeutics ( NTLA 4.88%) could easily experience another leg up if there's a bull market in the latter half of 2023. With positive ...Jun 5, 2023 · Intellia Therapeutics ( NTLA -3.53%) works in the up-and-coming area of gene editing. Invitae ( NVTA 0.75%) specializes in genetic testing. Both stocks have declined over the past year. But Wall ... Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis.Jul 6, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceAbout the Roku, Inc. stock forecast. As of 2023 November 30, Thursday current price of ROKU stock is 106.720$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Roku Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments …Intellia Therapeutics (NTLA 2.54%) works in the up-and-coming area of gene editing. Invitae ( NVTA -0.52% ) specializes in genetic testing. Both stocks have declined over the past year.Intellia Therapeutics (NASDAQ: NTLA) stock represents a company utilizing CRISPR/Cas9, a powerful tool for precisely and efficiently editing genetic sequences.The company is using this technology ...While many growth stocks have rallied in 2023, Exelixis stock has moved up and down since the start of the year. ... NTLA-2002 could be a game-changing treatment for hereditary angiodema (HAE), a ...View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Intellia Therapeutics (NASDAQ: NTLA) stock represents a company utilizing CRISPR/Cas9, a powerful tool for precisely and efficiently editing genetic sequences.The company is using this technology ...NTLA Pre-Market Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. According to our current EDIT stock forecast, the value of Editas Medicine shares will drop by -23.77% and reach $ 8.03 per share by December 6, 2023. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).EDIT stock recorded 14/30 (47%) green days with 19.75% price volatility over the …Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Jun 13, 2023 · Intellia's Q1 2023 financial report shows a cash position of $1.2 billion, with collaboration revenue rising to $12.6 million and a net loss of $103.1 million. The success of NTLA-2002 in further ... Stocks making the biggest moves midday: Tesla, Disney, Alibaba, Ulta Beauty and more. Published Fri, Dec 1 202312:20 PM EST. Samantha Subin …For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.40 per share, missing the Zacks Consensus Estimate of -$1.32 per share. This reflects a negative earnings surprise of ...Some of the best biotech stocks to buy according to hedge funds include Pfizer Inc. (NYSE: PFE ), Illumina, Inc. (NASDAQ: ILMN ), and United Therapeutics Corporation (NASDAQ: UTHR ).May 10, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Caribou Biosciences, Inc. 5.69. +0.39. +7.36%. In this article, we discuss 10 best gene editing stocks to buy. If you want to see more stocks in this selection, check out 5 Best Gene Editing ...Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Regeneron Pharmaceuticals's REGN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...The stock is trading at $62.69 and its $108.64 indicates a 73% one-year gain lying ahead for NTLA. (See NTLA stock forecast on TipRanks)To find good ideas for stocks trading at attractive ...Jun 13, 2023 · Intellia's Q1 2023 financial report shows a cash position of $1.2 billion, with collaboration revenue rising to $12.6 million and a net loss of $103.1 million. The success of NTLA-2002 in further ... NTLA stock forecast for 2023 – 2027. Last updated: November 23, 2023. NTLA. Intellia Therapeutics, Inc. 30.26 D 6.32% (1.80) Are you interested in Intellia Therapeutics, Inc. stocks prediction?See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Intellia Therapeutics (NTLA) Stock Forecast & Price Prediction. Estimation of the future price movement of Intellia Therapeutics stock, based on various factors such as …21 analysts have issued 1-year price objectives for Intellia Therapeutics' stock. Their NTLA share price targets range from $40.00 to $136.00. On average, they …Apr 18, 2023 · That revenue goes along with positive earnings per share of $12.83 in 2022. And the forecast is that Vertex will grow earnings in 2023. ... Analysts are bullish on NTLA stock. It currently has a ... Apr 18, 2023 · That revenue goes along with positive earnings per share of $12.83 in 2022. And the forecast is that Vertex will grow earnings in 2023. ... Analysts are bullish on NTLA stock. It currently has a ... Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Forecast . Price target. 76.00 0.00 0.00%. The 24 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —. Analyst rating. Based on 27 analysts giving stock ratings to NTLA in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreFind the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. Analysts are bullish on NTLA stock. It currently has a mean price target of $97.19 which would be a gain of over 154% from the current price and institutional investors own approximately 85% of ...Nov 30, 2023 · The average twelve-month price prediction for Intellia Therapeutics is $77.70 with a high price target of $136.00 and a low price target of $40.00. Learn more on NTLA's analyst rating history. Do Wall Street analysts like Intellia Therapeutics more than its competitors? Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the last price of 26.16. Intellia Therapeutics last released its quarterly earnings results on November 9th, 2023. The reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.52) by $0.14. The firm earned $11.99 million during the quarter, compared to the consensus estimate of $12.45 million.The average Editas Medicine stock forecast 2024 represents a 3.79% increase from the last price of $10.5299997329712. For Editas Medicine stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Editas Medicine stock forecast of $10.98, a high forecast of $12.02, and a low forecast of $10.15.A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.EXEL : EXELIXIS INC stock forecast by Wall Street Analysts. The average EXELIXIS INC stock forecast from last 6 month is $25.28, and this show a 7.89% increase in average from the prior price target of the each prediction. Also, this average forecast of $25.28 represents a 1.73% increase from the past average forecast of $24.85, 6 months ago from 13 wall …Intellia Therapeutics is a genome editing company that develops curative therapeutics for various diseases. The company's stock price, news, and analysis are shown on the web page, as well as its market cap, P/E ratio, dividend yield, and price target. The company has a consensus rating of Moderate Buy and a forecasted upside of 228.3%.Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceMay 10, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance 2014. 598. John Leonard. https://www.intelliatx.com. Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary ...The current Intellia Therapeutics [ NTLA] share price is $28.76. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. Investing in These 3 Healthcare Stocks Could Double Your Money, Says Credit Suisse. By Billy C. Redd Last updated May 10, 2022. Share. On Wall Street, some things never change. High inflation or not, the fact remains that health stocks are the epitome of risk/reward games. Why? It depends on the nature of the industry itself.Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target NTLA. High $ 145.00: Median $ 72.00: Low $ 29.00: Average $ 76.00: Current ...Intellia Therapeutic’s stock (NASDAQ NDAQ +3.2%: NTLA), a biotechnology company developing treatments using the CRISPR gene-editing system, has seen a fall of 31% in a month, while it’s down ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Nov 3, 2023 · Intellia Therapeutics Stock Forecast 2023. In the last five quarters, Intellia Therapeutics’s Price Target has risen from $0.00 to $25.05 - a 100% increase. Three analysts predict that Intellia Therapeutics’s share price will increase in the coming year, reaching $72.00. This would represent an increase of 187.43%. While many growth stocks have rallied in 2023, Exelixis stock has moved up and down since the start of the year. ... NTLA-2002 could be a game-changing treatment for hereditary angiodema (HAE), a ...AAPL. 189.69. -0.01%. 49.41M. View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.Find real-time NTLA - Intellia Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. As of March 29, 2023, 4:00 PM CST, Intellia Therapeutics Inc’s stock price was $37.56. Intellia Therapeutics Inc is up 4.28% from its previous closing price of $36.02. During the last market session, Intellia Therapeutics Inc’s stock traded between $35.98 and $37.55. Currently, there are 81.26 million shares of Intellia Therapeutics Inc ...Current. -$1.48. 1 Month Ago. -$1.60. 3 Months Ago. -$1.63. Intellia Therapeutics Inc. analyst estimates, including NTLA earnings per share estimates and analyst recommendations.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...The stock price of Intellia Therapeutics (NASDAQ: NTLA), a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid 15% rise over the last five trading days ...See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Price Forecast. The 25 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 90.10, with a high estimate of 116.00 and a low estimate of 71.00. The ...But Intellia has two programs in early-stage trials that could make this a monster stock in the future. NTLA-2001 is an in vivo gene-editing treatment for transthyretin amyloidosis, a condition ...٢٠‏/٠٧‏/٢٠٢٣ ... As of Thursday, July 20, Intellia Therapeutics Inc's NTLA share price has dipped by 5.13%, which has investors questioning if this is right ...NTNX one year forecast. Nutanix stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast NTNX stock forecast for 2023 – 2027. Last updated: November 16, 2023. Are you interested in Nutanix, Inc. stocks prediction? ... NTLA Stock Forecast; NTIP Stock Forecast;Apr 20, 2023 · The stock is selling for $100.49, and its $155.67 average price target is almost identical to Nowinski’s objective. (See Zscaler stock forecast ) Intellia Therapeutics ( NTLA ) AAPL. 189.69. -0.01%. 49.41M. View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.Apr 18, 2023 · That revenue goes along with positive earnings per share of $12.83 in 2022. And the forecast is that Vertex will grow earnings in 2023. ... Analysts are bullish on NTLA stock. It currently has a ... Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Intellia Therapeutics Inc (NTLA) Stock Price & News - Google Finance Home NTLA • NASDAQ Intellia Therapeutics Inc Follow Share $30.93 After Hours: $31.14 (0.68%) …Nov 24, 2023 · The Intellia Therapeutics Inc stock price gained 2.54% on the last trading day (Friday, 24th Nov 2023), rising from $30.26 to $31.03. During the last trading day the stock fluctuated 5.87% from a day low at $30.13 to a day high of $31.90. The price has risen in 6 of the last 10 days and is up by 24.32% over the past 2 weeks. But Intellia has two programs in early-stage trials that could make this a monster stock in the future. NTLA-2001 is an in vivo gene-editing treatment for transthyretin amyloidosis, a condition ...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.The average twelve-month price prediction for Intellia Therapeutics is $77.70 with a high price target of $136.00 and a low price target of $40.00. Learn more on NTLA's analyst rating history. Do Wall Street analysts like Intellia Therapeutics more than its competitors?Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.Ntla stock forecast

Current. -$1.48. 1 Month Ago. -$1.60. 3 Months Ago. -$1.63. Intellia Therapeutics Inc. analyst estimates, including NTLA earnings per share estimates and analyst recommendations. . Ntla stock forecast

ntla stock forecast

Intellia Therapeutics Stock Forecast 2023. In the last five quarters, Intellia Therapeutics’s Price Target has risen from $0.00 to $25.05 - a 100% increase. Three analysts predict that Intellia Therapeutics’s share price will increase in the coming year, reaching $72.00. This would represent an increase of 187.43%.What this means: InvestorsObserver gives Intellia Therapeutics Inc. (NTLA) an overall rank of 36, which is below average. Intellia Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 36 means that 64% of stocks appear more favorable to our system.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Unitedhealth Group Inc () Stock Market info Recommendations: Buy or sell Unitedhealth Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Unitedhealth Group share forecasts, stock quote and buy / sell signals below.According to present data Unitedhealth Group's UNH shares and potentially its …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceThe anecdotal wisdom is that the way to outperform the market this year has been to flock to the Magnificent Seven stocks (AAPL, AMZN, Google, META, MSFT, Latest NewsDosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to ...May 4, 2023 · As for financials, the company’s top line and bottom line beat Street forecasts while its cash, cash equivalents, and marketable securities stood at $1.2B at the end of the quarter compared to ... Oct 15, 2020 · About the Intellia Therapeutics, Inc. stock forecast. As of 2023 November 30, Thursday current price of NTLA stock is 30.900$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the …Oct 18, 2023 · On today's stock market, NTLA stock skidded 3.8%, reversing from a premarket climb and closing at 27.96. Shares of Regeneron Pharmaceuticals ( REGN ), which is collaborating with Intellia on the ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceAnalysts rate Intellia Therapeutics Inc. with a consensus Strong Buy rating with an average 12-months Intellia stock price target of $166.36 per shareEXEL : EXELIXIS INC stock forecast by Wall Street Analysts. The average EXELIXIS INC stock forecast from last 6 month is $25.28, and this show a 7.89% increase in average from the prior price target of the each prediction. Also, this average forecast of $25.28 represents a 1.73% increase from the past average forecast of $24.85, 6 months ago from 13 wall …The stock price of Intellia Therapeutics (NASDAQ: NTLA), a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid 15% rise over the last five trading days ...The European Commission bestows orphan drug designation to Intellia's (NTLA) in vivo CRISPR-based investigational therapy, NTLA-2002, for treating hereditary angioedema. Stock rises. AdvertisementIntellia Therapeutics is a genome editing company that develops curative therapeutics for various diseases. The company's stock price, news, and analysis are shown on the web page, as well as its market cap, P/E ratio, dividend yield, and price target. The company has a consensus rating of Moderate Buy and a forecasted upside of 228.3%.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Intellia Therapeutics last released its quarterly earnings results on November 9th, 2023. The reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.52) by $0.14. The firm earned $11.99 million during the quarter, compared to the consensus estimate of $12.45 million.Jun 28, 2021 · Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics. ... And for 2028, analysts forecast the sector to bring in revenue ... The Intellia Therapeutics stock forecast for tomorrow is $ 30.29, which would represent a -1.78% loss compared to the current price. In the next week, the price of NTLA is expected to increase by 11.80% and hit $ 34.48.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.Current. -$1.48. 1 Month Ago. -$1.60. 3 Months Ago. -$1.63. Intellia Therapeutics Inc. analyst estimates, including NTLA earnings per share estimates and analyst recommendations. Read why NTLA stock is a Buy. Intellia is a pipeline-stage firm, leveraging gene-editing technology to develop therapies for rare diseases. ... So, I forecast NTLA’s cash flow statement using ...Do you wonder where the stock market is headed? Well, Wells Fargo’s senior global market strategist, Scott Wren, believes that the S&P 500 will remain range-bound, with a low end around 3,600 and a top end around 4,300, for the remainder of the year. Wren’s advice is not to chase the market when it nears that peak, but to make use …(See NTLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks’ equity insights.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Apr 21, 2023 · (See NTLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy , a newly launched tool that unites all of TipRanks’ equity insights. Find real-time STLA - Stellantis NV stock quotes, company profile, news and forecasts from CNN Business.NTLA Stock Price Performance Analysis. Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -15.08%. However, over the last six months, the performance has been …Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (ARKK 1.26% ...١٥‏/٠٦‏/٢٠٢٣ ... Warning flags for any stock MBOT's arbitrary price targets ... Is NTLA the Best Gene Editing Stock? Nanalyze New 654 views · 43:57. Go ...In the same period, the company plans to submit an IND for NTLA-3001, its therapy for alpha-1 antitrypsin deficiency-related lung disease that's presently in early-stage trials.Teradyne Stock Forecast 05-20-2022. Forecast target price for 05-20-2022: $ 106.94. Positive dynamics for Teradyne shares will prevail with possible volatility of 2.637%. Pessimistic target level: 105.08. Optimistic target level: 107.92.View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00.Disney stock price predictions for November 2024. The forecast for beginning of November 106. Maximum value 117, while minimum 103. Averaged Disney stock price for month 109. Price at the end 110, change for November 3.77%. NTLA Stock Forecast 2023, 2024, 2025.Intellia Therapeutics Stock Forecast 2023. In the last five quarters, Intellia Therapeutics’s Price Target has risen from $0.00 to $25.05 - a 100% increase. Three analysts predict that Intellia Therapeutics’s share price will increase in the coming year, reaching $72.00. This would represent an increase of 187.43%.The average one-year price target for NTLA / Intellia Therapeutics Inc is $84.617. The forecasts range from a low of $38.38 to a high of $164.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to …What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...Earnings vs Market: NTLA is forecast to remain unprofitable over the next 3 years. High Growth Earnings : NTLA is forecast to remain unprofitable over the next 3 …Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings within the last quarter: These 12 analysts have an average price target of $77.5 versus the current price of Intellia ...Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.Gene editing stocks, led by NTLA stock, ... And for 2028, analysts forecast the sector to bring in revenue of $62.9 billion. Bionano Genomics’ flagship product is Saphyr, ...Nov 29, 2023 · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. As of July 20, 2023, 4:00 PM CST, Intellia Therapeutics Inc’s stock price was $43.28. Intellia Therapeutics Inc is down 5.13% from its previous closing price of $45.62. During the last market session, Intellia Therapeutics Inc’s stock traded between $44.60 and $46.00. Currently, there are 87.77 million shares of Intellia Therapeutics Inc ...The average Intellia Therapeutics stock forecast 2024 represents a -6.43% decrease from the last price of $30.8400001525879. For Intellia Therapeutics stock forecast for 2025, 12 predictions are offered for each month of 2025 with average Intellia Therapeutics stock forecast of $31.28, a high forecast of $34.48, and a low forecast …Stock Price Forecast. According to 20 stock analysts, the average 12-month stock price forecast for NTLA stock stock is $77.4, which predicts an increase …NTLA Stock Price Performance Analysis. Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -15.08%. However, over the last six months, the performance has been …The average twelve-month price prediction for Intellia Therapeutics is $77.70 with a high price target of $136.00 and a low price target of $40.00. Learn more on NTLA's analyst rating history. Do Wall Street analysts like Intellia Therapeutics more than its competitors?Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsMorningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating …The current Intellia Therapeutics [ NTLA] share price is $28.76. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Forecast . Price target. 76.00 0.00 0.00%. The 24 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —. Analyst rating. Based on 27 analysts giving stock ratings to NTLA in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreThe Vanguard Group, Inc. is the second largest shareholder owning 9.2% of common stock, and BlackRock, Inc. holds about 9.1% of the company stock. Furthermore, CEO John Leonard is the owner of 0.9 ...About the Intellia Therapeutics, Inc. stock forecast. As of 2023 November 30, Thursday current price of NTLA stock is 30.900$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceIntellia Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing ...NTLA Stock Dives As Competition Heats Intellia tested four doses of its one-time drug. The best response came from the highest dose, which led to a 93% average reduction in transthyretin protein.NTLA Stock Forecast 2023, 2024, 2025 2023/11/18. Intellia Therapeutics stock predictions for next months and years. Intellia Therapeutics stock price …The average one-year price target for NTLA / Intellia Therapeutics Inc is $84.617. The forecasts range from a low of $38.38 to a high of $164.85. A stock’s price target is the price at which analysts consider it fairly valued with respect to …View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time …What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...Shares of Intellia Therapeutics, Inc. (NTLA) have gained 23.5% over the past four weeks to close the last trading session at $43.19, but there could still be a solid upside left in the stock if ...Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Nov 24, 2023 · Intellia Therapeutics is a genome editing company that develops curative therapeutics for various diseases. The company's stock price, news, and analysis are shown on the web page, as well as its market cap, P/E ratio, dividend yield, and price target. The company has a consensus rating of Moderate Buy and a forecasted upside of 228.3%. Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to ...View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time …The Intellia Therapeutics Inc stock price gained 2.54% on the last trading day (Friday, 24th Nov 2023), rising from $30.26 to $31.03. During the last trading day the stock fluctuated 5.87% from a day low at $30.13 to a day high of $31.90. The price has risen in 6 of the last 10 days and is up by 24.32% over the past 2 weeks.Intellia Therapeutics ( NASDAQ: NTLA) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target NTLA. High $ 145.00: Median $ 72.00: Low $ 29.00: Average $ 76.00: Current ... Nov 29, 2023 · See the latest Intellia Therapeutics Inc stock price (NTLA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Regeneron Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Regeneron Pharmaceuticals's REGN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).NTLA Revenue (Quarterly) data by YCharts. More than $1 billion in cash At the same time, though, Intellia reported $1.1 billion in cash during its most recent earnings call and about $200 million ...Gov.capital. Intellia Therapeutics (NTLA) stock price prediction is 94.108148888185 USD. The Intellia Therapeutics stock forecast is 94.108148888185 …The Invitae Corp ( NVTA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.8754, representing a +617.26% increase from the current price of $0.5403. The highest analyst price target is $7.6988, and the lowest is $0.0519. Based on our technical indicators, the current sentiment is ...November 14, 2025 Intellia Therapeutics Company Overview – November 2023. June 12, 2023 NTLA-2002 Interim Clinical Update – June 12, 2023. November 14, 2022 NTLA-2002 Interim Clinical Data Update – November 14, 2022. September 16, 2022 In vivo CRISPR/Cas9 editing of KLKB1 in patients with HAE – September 16, 2022.NTLA After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.17 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.96 per share a year ago.. How to get a mortgage without tax returns